27. November 2012CE Mark Indication for cobas 4800 HPV Test Supporting Its Use as a Primary Screen for Cervical CancerThe newly expanded indication for the cobas® 4800 HPV Test as a primary screen means Pap cytology is no longer required as a co- or pre-test in countries that accept a CE mark.more 25. July 2012Roche expands its blood screening portfolioNew solution improves safety of donated blood
more 05. July 2012Roche receives FDA approval for Cytomegalovirus viral load testFirst FDA-approved laboratory test for quantifying DNA of potentially deadly virus helps physicians manage organ transplant patients on antiviral therapy
more 02. July 2012Roche announces FDA approval of HIV viral load testTest is based on innovative dual-target approachmore 30. March 2012Roche receives FDA approval for cobas p 630 pre-analytical solution for automated molecular testing platformRoche announced the FDA approval of a new pre-analytical instrument that provides an integrated primary tube handling solution for its widely adopted automated molecular testing platform.
more 15. March 2012New Professional Guidelines Recognize Benefit of Genotyping HPV 16 and 18 for Cervical Cancer Prevention by Assessing Individual Patient RiskFor the first time, three professional organizations together issued guidelines that using human papillomavirus (HPV) testing in addition to a Pap test (also known as co-testing) is preferable to using a Pap test alone for women 30 years and older. more 22. February 2012Roche and Life Technologies Corporation Sign New PCR IVD LicensesRoche and Life Technologies Corporation announced that they have entered into two license agreements to allow LTC to expand its PCR offerings for diagnostics applications. more 01. February 2012Roche receives FDA clearance for test to screen and diagnose chlamydia and gonorrhea infection in symptomatic and asymptomatic patientsNew cobas CT/NG test expands cobas 4800 system menu beyond clinically proven HPV test to further enhance laboratory efficiency, automation capabilitiesmore 05. January 2012Roche’s novel tests for the management of hepatitis C virus infection receive CE MarkThe tests detect HCV RNA, which is a crucial marker in the management of hepatitis C infection. more